Evidence map›Paper›PMID 42668986›Full record

ArticleJournal of hepatocellular carcinoma2026

Outcomes of Preoperative TACE vs Upfront Hepatectomy in Hepatocellular Carcinoma: A Single-Center Retrospective Study in Vietnam.

Anh Gia Pham, Nghia Trung Bui, Thau Manh Cao, Son Hong Trinh, Huyen Trang Thi Vo, Lam Thanh Phan, Thu Hang Thi Nguyen, Tung Thanh Pham, Hang Thu Nong, Ngoc Thi Tran and 1 more

Abstract read
In one paragraph

Article in Journal of hepatocellular carcinoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anh Gia PhamDepartment of Oncology and Radiotherapy, Viet Duc University Hospital, Hanoi, Vietnam.ORCID 0000-0003-2580-0955
Nghia Trung BuiDepartment of Oncology and Radiotherapy, Viet Duc University Hospital, Hanoi, Vietnam.ORCID 0000-0003-4015-2415
Thau Manh CaoDepartment of Oncology and Radiotherapy, Viet Duc University Hospital, Hanoi, Vietnam.ORCID 0000-0002-2448-9475
Son Hong TrinhDepartment of Oncology and Radiotherapy, Viet Duc University Hospital, Hanoi, Vietnam.
Huyen Trang Thi VoDepartment of Oncology and Radiotherapy, Viet Duc University Hospital, Hanoi, Vietnam.ORCID 0009-0005-1127-2233
Lam Thanh PhanDepartment of Oncology and Radiotherapy, Viet Duc University Hospital, Hanoi, Vietnam.ORCID 0009-0009-6405-9048
Thu Hang Thi NguyenDepartment of Oncology and Radiotherapy, Viet Duc University Hospital, Hanoi, Vietnam.ORCID 0009-0000-2821-7488
Tung Thanh PhamDepartment of Oncology and Radiotherapy, Viet Duc University Hospital, Hanoi, Vietnam.ORCID 0009-0003-6693-9416
Hang Thu NongDepartment of Oncology and Radiotherapy, Viet Duc University Hospital, Hanoi, Vietnam.ORCID 0009-0002-0397-011X
Ngoc Thi TranDepartment of Oncology and Radiotherapy, Viet Duc University Hospital, Hanoi, Vietnam.ORCID 0009-0006-5601-0701
Cong Tien BuiDepartment of Oncology and Radiotherapy, Viet Duc University Hospital, Hanoi, Vietnam.ORCID 0000-0002-4133-2322

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This propensity score-matched study aimed to compare survival outcomes between preoperative TACE followed by hepatectomy and upfront hepatectomy in patients with resectable hepatocellular carcinoma. Patients and Methods: In this single-center retrospective cohort study at Viet Duc University Hospital, 304 consecutive patients with resectable HCC treated between January 2015 and October 2024 were analyzed: 168 underwent upfront hepatectomy and 136 received preoperative TACE followed by hepatectomy. Propensity score matching (PSM; 1:1 nearest-neighbor, caliper 0.01) was performed to balance pre-treatment covariates between groups. Overall survival (OS) and disease-free survival (DFS) were compared using Kaplan-Meier analysis and the Log rank test. Independent prognostic factors were identified using multivariable Cox regression. Results: Median follow-up was 58.9 months. After PSM (113 matched pairs), median OS was not reached in the upfront hepatectomy group versus 62.5 months in the preoperative TACE group (P = 0.322), and median DFS was 32.0 versus 29.2 months (P = 0.056). In multivariable Cox analysis of the matched cohort, preoperative TACE was not independently associated with OS (HR 1.15, 95% CI 0.74-1.79; P = 0.526) or DFS (HR 1.19, 95% CI 0.92-1.75; P = 0.130), whereas advanced TNM stage (OS: HR 2.45, 95% CI 1.08-5.52, P = 0.032; DFS: HR 2.26, 95% CI 1.14-4.46, P = 0.019) and microvascular invasion (OS: HR 1.48, 95% CI 1.09-2.40, P = 0.007; DFS: HR 1.52, 95% CI 1.01-2.29, P = 0.035) remained independent prognostic factors. Within the TACE group, patients achieving complete pathological necrosis (n = 26) had OS and DFS comparable to upfront hepatectomy, whereas incomplete or partial necrosis was associated with significantly worse survival (P = 0.05 for OS and P = 0.01 for DFS). Conclusion: In this retrospective, propensity score-matched cohort, preoperative TACE was not associated with improved overall or disease-free survival in patients with resectable HCC and does not appear justified as a routine strategy in patients who are already surgical candidates. Because the analysis was retrospective and residual confounding cannot be excluded, these findings should be regarded as hypothesis-generating. Any role for preoperative TACE in selected settings, such as borderline resectability or when complete tumor necrosis is achieved, requires prospective confirmation.

Indexed as

hepatectomyhepatocellular carcinomamicrovascular invasionpreoperativeTACE

Identifiers

PMID42668986
PMCPMC13525807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.